Abstract:We examined 1he Na*/H+ exchanger message in isolated perfused rabbi1 hear15 using Northern blot analysis with cDNA encoding for the rabbit cardiac Na*/H* exchanger. A cDNA probe from the coding region of the rabbit myocardial Na'Al' exchanger hybridized to mRNA of 5 kb under high stringency, and to a second 3.8 kb mRNA species under low stringency. When Northern blots were re-probed with a section of the 3'-untransla1ed region of the cDNA, the 5 kb message w3s apparent while 1hc smaller 3.8 kb message was nol.… Show more
“…In addition to these in silico analyses, support for alternate splicing can be found in previous work. First, early after the cloning of NHE1, short-length transcripts have been described in rabbit myocardium (Dyck et al 1992). Second, amongst two alternate transcripts detected in brain and lung from engineered Slc9A1 knockout mice, one was shown to have an in-phase downstream sequence that can produce an intact C-terminus peptide (Bell et al 1999).…”
C exchangers (NHE) constitute a family of membrane antiporters that contribute to the regulation of cellular pH and volume in many tissues, including pancreatic islets. We investigated the molecular identity of NHE in rodent and human endocrine pancreas, and determined its cellular and subcellular localization. NHE1 was the most abundantly expressed isoform in rat islets, and was also expressed in mouse and human islets. By western blot, an antiserum raised against the C-terminus end of NHE1 confirmed the presence of a w100 kDa protein corresponding to NHE1 in islets and unexpectedly unveiled the existence of a w65 kDa cross-reactive NHE1-related protein. By immunohistochemistry, the antiserum labelled the membranes of pancreatic acini and ducts, but also diffusely stained the cytoplasm of insulin, glucagon and somatostatin cells as well as endocrine cells of the adrenal medulla. Electron microscopy localized the NHE1 immunoreactivity in the membrane of secretory granules, an unexpected finding supported by a decrease in immunohistochemical signal in degranulated b-cells. Islets of Slc9A1 swe/swe mice, which lack full NHE1 protein, were found to express an mRNA corresponding to the 3 0 end of NHE1 as well as the w65 kDa protein. They still showed the cytoplasmic labelling but no plasma membrane was stained. We conclude that both the full-length and the shorter-splice variant of NHE1 are expressed in all cell types of the endocrine pancreas and in the adrenal medulla of rodents and humans. The complete protein is addressed to the plasma membrane and the shorter one to the membrane of secretory granules where its function remains to be established.
“…In addition to these in silico analyses, support for alternate splicing can be found in previous work. First, early after the cloning of NHE1, short-length transcripts have been described in rabbit myocardium (Dyck et al 1992). Second, amongst two alternate transcripts detected in brain and lung from engineered Slc9A1 knockout mice, one was shown to have an in-phase downstream sequence that can produce an intact C-terminus peptide (Bell et al 1999).…”
C exchangers (NHE) constitute a family of membrane antiporters that contribute to the regulation of cellular pH and volume in many tissues, including pancreatic islets. We investigated the molecular identity of NHE in rodent and human endocrine pancreas, and determined its cellular and subcellular localization. NHE1 was the most abundantly expressed isoform in rat islets, and was also expressed in mouse and human islets. By western blot, an antiserum raised against the C-terminus end of NHE1 confirmed the presence of a w100 kDa protein corresponding to NHE1 in islets and unexpectedly unveiled the existence of a w65 kDa cross-reactive NHE1-related protein. By immunohistochemistry, the antiserum labelled the membranes of pancreatic acini and ducts, but also diffusely stained the cytoplasm of insulin, glucagon and somatostatin cells as well as endocrine cells of the adrenal medulla. Electron microscopy localized the NHE1 immunoreactivity in the membrane of secretory granules, an unexpected finding supported by a decrease in immunohistochemical signal in degranulated b-cells. Islets of Slc9A1 swe/swe mice, which lack full NHE1 protein, were found to express an mRNA corresponding to the 3 0 end of NHE1 as well as the w65 kDa protein. They still showed the cytoplasmic labelling but no plasma membrane was stained. We conclude that both the full-length and the shorter-splice variant of NHE1 are expressed in all cell types of the endocrine pancreas and in the adrenal medulla of rodents and humans. The complete protein is addressed to the plasma membrane and the shorter one to the membrane of secretory granules where its function remains to be established.
“…Northern analysis revealed a message in testis which is smaller than the NHE-1 message in other tissues [26]. Dyck et al [45] recently reported a smaller (3.8 kb) message in ischaemic hearts. This message hybridized with different NHE-l cDNA probes derived from the open reading frame but not from the untranslated regions.…”
Section: The Na+/h+ Exchanger and Its Isoformsmentioning
confidence: 99%
“…When rat hearts are subjected to relatively short periods of ischaemia, intracellular acidosis occurs. This results in a small increase in NHE-I mRNA levels and a larger increase in a related isoform (3.8 kb) of the message [45]. Primary cultures of isolated myocytes also increase Na+/H+ exchanger activity in response to exposure to external media of low pH (L. Fliegel, unpublished work).…”
Section: Regulation Of the Na+/h+ Exchangermentioning
confidence: 99%
“…Screening of rabbit and rat heart cDNA libraries led only to clones of NHE-1 [22,26]. In addition, Northern blot analysis of heart muscle mRNA with NHE-1 probes reveals mainly the message size of 5 kb that is consistent with NHE-1 [26,45]. However, a smaller message of 3.8 kb also hybridizes to NHE-1 probes under low stringency, which becomes more pronounced after ischaemic exposure [45].…”
Section: The Myocardial Na+/h+ Exchanger In Health and Diseasementioning
This cDNA clone was isolated by complementation of an exchanger-deficient cell line. * This site also contains an R residue, two amino acids after the serine, forming consensus sequence XRXXSXRX. One example of each species was used for each isoform except for NHE-2, which varied between the tissues. Only full-length sequences were used for analysis.
“…Cardiac cells do not possess NHE2–5 [ 46 , 47 , 48 , 49 ] and NHE6–9 are localized to intracellular organelle membranes such as mitochondria, endosomes and the Golgi network so they do not directly contribute to proton extrusion from cardiomyocytes [ 50 , 51 ]. cDNA for NHE1 codes for the identical NHE1 message as in other tissues [ 29 ] and though a different size mRNA for NHE1 has been shown to occur in ischemic conditions [ 52 ], this does not code for a functional protein. exchange has been clearly demonstrated in cardiac sarcolemma vesicles where it was inhibited by amiloride [ 28 , 53 ].…”
Section: Expression and Localization Of Myocardial Nhe1mentioning
The mammalian Na + /H + exchanger (NHE) is a family of ubiquitous membrane proteins present in humans. Isoform one (NHE1) is present on the plasma membrane and regulates intracellular pH by removal of one intracellular proton in exchange for one extracellular sodium thus functioning as an electroneutral process. Human NHE1 has a 500 amino acid membrane domain plus a C-terminal 315 amino acid, regulatory cytosolic tail. It is regulated through a cytosolic regulatory C-terminal tail which is subject to phosphorylation and is modulated by proteins and lipids. Substantial evidence has implicated NHE1 activity in both myocardial ischemia and reperfusion damage and myocardial remodeling resulting in heart failure. Experimental data show excellent cardioprotection with NHE1 inhibitors although results from clinical results have been mixed. In cardiac surgery patients receiving the NHE1 inhibitor cariporide, subgroups showed beneficial effects of treatment. However, in one trial this was associated with a significantly increased incidence of ischemic strokes. This likely reflected both inappropriate dosing regimens as well as overly high drug doses. We suggest that further progress towards NHE1 inhibition as a treatment for cardiovascular disease is warranted through the development of novel compounds to inhibit NHE1 that are structurally different than those previously used in compromised clinical trials. Some novel pyrazinoyl guanidine inhibitors of NHE1 are already in development and the recent elucidation of the three-dimensional structure of the NHE1 protein and identity of the inhibitor binding site may facilitate development. An alternative approach may also be to control the endogenous regulation of activity of NHE1, which is activated in disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.